Chemomab Therapeutics (CMMB) Prepaid Assets (2019 - 2025)

Chemomab Therapeutics (CMMB) has 7 years of Prepaid Assets data on file, last reported at $3.1 million in Q4 2025.

• For the quarter ending Q4 2025, Prepaid Assets rose 80.15% year-over-year to $3.1 million; the trailing twelve-month figure through Dec 2025 stood at $3.1 million (up 80.15% YoY), and the FY2025 full-year result was $3.1 million, up 80.15% from the prior year.
• Prepaid Assets for Q4 2025 stood at $3.1 million, up from $1.7 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $3.1 million in Q2 2022 and bottomed at $320000.0 in Q1 2021.
• The 5-year median for Prepaid Assets is $1.7 million (2022), against an average of $1.8 million.
• The widest annual swing landed in 2021, when Prepaid Assets soared 982.98%; it then tumbled 48.55% in 2023.
• A 5-year view of Prepaid Assets shows it stood at $1.5 million in 2021, then rose by 15.65% to $1.8 million in 2022, then slumped by 41.28% to $1.0 million in 2023, then surged by 63.74% to $1.7 million in 2024, then jumped by 80.15% to $3.1 million in 2025.
• The last three Prepaid Assets figures came in at $3.1 million (Q4 2025), $1.7 million (Q4 2024), and $1.0 million (Q4 2023), per Business Quant data.

Peer Comparison